See the DrugPatentWatch profile for cosentyx

The Cost of Cosentyx: A Conversation with Your Physician

As a patient considering Cosentyx (secukinumab) for the treatment of psoriasis, psoriatic arthritis, or ankylosing spondylitis, it's essential to discuss the cost with your physician. Cosentyx is a biologic medication that has shown significant efficacy in treating these conditions, but its price tag can be steep. In this article, we'll explore the cost of Cosentyx, how it compares to other treatments, and what you can expect to pay out-of-pocket.

What is Cosentyx and How Does it Work?

Cosentyx is a monoclonal antibody that targets interleukin-17A (IL-17A), a protein involved in the inflammatory response. By blocking IL-17A, Cosentyx reduces inflammation and slows down the progression of psoriasis, psoriatic arthritis, and ankylosing spondylitis. According to the manufacturer, Novartis, Cosentyx has been shown to improve symptoms and quality of life for patients with these conditions.

The Cost of Cosentyx

The cost of Cosentyx varies depending on the dosage, frequency of administration, and location. According to DrugPatentWatch.com, a website that tracks pharmaceutical patents and prices, the wholesale acquisition cost (WAC) of Cosentyx is around $6,000 to $7,000 per year for a 300mg dose, administered every 4 weeks. This translates to a monthly cost of around $1,000 to $1,200.

Comparing Cosentyx to Other Treatments

Cosentyx is not the only treatment option for psoriasis, psoriatic arthritis, and ankylosing spondylitis. Other biologic medications, such as Humira (adalimumab) and Enbrel (etanercept), may be more affordable. However, these medications may not be as effective as Cosentyx, and their prices can vary depending on the dosage and frequency of administration.

What to Expect to Pay Out-of-Pocket

The out-of-pocket cost of Cosentyx can be significant, especially for patients without insurance or with high deductibles. According to a study published in the Journal of Clinical and Aesthetic Dermatology, patients with psoriasis who were prescribed Cosentyx reported paying an average of $2,500 to $3,000 per year out-of-pocket. This can be a significant burden for patients who are already struggling with the financial implications of their condition.

Talking to Your Physician about Cost

When discussing Cosentyx with your physician, it's essential to ask about the cost and potential alternatives. Your physician may be able to recommend more affordable treatment options or provide guidance on how to access financial assistance programs. According to Dr. Mark Lebwohl, a dermatologist and professor at the Icahn School of Medicine at Mount Sinai, "Patients should always ask about the cost of treatment and potential alternatives. It's essential to have an open and honest conversation with your physician about your financial situation and treatment options."

Financial Assistance Programs

Novartis, the manufacturer of Cosentyx, offers several financial assistance programs to help patients access the medication. These programs include:

* Cosentyx Savings Card: This program offers a discount of up to $1,000 per year on the out-of-pocket cost of Cosentyx.
* Cosentyx Patient Assistance Program: This program provides free or reduced-cost Cosentyx to eligible patients who cannot afford the medication.
* Novartis Patient Assistance Foundation: This foundation provides financial assistance to patients who are struggling to pay for their medication.

Conclusion

The cost of Cosentyx is a significant concern for patients considering this medication for the treatment of psoriasis, psoriatic arthritis, or ankylosing spondylitis. While it may be an effective treatment option, its price tag can be steep. By discussing the cost with your physician and exploring financial assistance programs, you can make an informed decision about your treatment options.

Key Takeaways

* Cosentyx is a biologic medication that targets interleukin-17A (IL-17A) to reduce inflammation and slow down the progression of psoriasis, psoriatic arthritis, and ankylosing spondylitis.
* The cost of Cosentyx varies depending on the dosage, frequency of administration, and location, with a wholesale acquisition cost (WAC) of around $6,000 to $7,000 per year.
* Patients should discuss the cost of Cosentyx with their physician and explore financial assistance programs to access the medication.
* Novartis offers several financial assistance programs, including the Cosentyx Savings Card, Cosentyx Patient Assistance Program, and Novartis Patient Assistance Foundation.

Frequently Asked Questions

1. Q: How much does Cosentyx cost per year?
A: The wholesale acquisition cost (WAC) of Cosentyx is around $6,000 to $7,000 per year for a 300mg dose, administered every 4 weeks.
2. Q: What are the financial assistance programs available for Cosentyx?
A: Novartis offers several financial assistance programs, including the Cosentyx Savings Card, Cosentyx Patient Assistance Program, and Novartis Patient Assistance Foundation.
3. Q: Can I get Cosentyx for free or reduced-cost?
A: Yes, Novartis offers a patient assistance program that provides free or reduced-cost Cosentyx to eligible patients who cannot afford the medication.
4. Q: How do I discuss the cost of Cosentyx with my physician?
A: It's essential to have an open and honest conversation with your physician about your financial situation and treatment options.
5. Q: Are there other treatment options for psoriasis, psoriatic arthritis, and ankylosing spondylitis?
A: Yes, there are several other biologic medications available, including Humira (adalimumab) and Enbrel (etanercept), which may be more affordable.

Sources

1. DrugPatentWatch.com: A website that tracks pharmaceutical patents and prices.
2. Journal of Clinical and Aesthetic Dermatology: A study published in this journal found that patients with psoriasis who were prescribed Cosentyx reported paying an average of $2,500 to $3,000 per year out-of-pocket.
3. Novartis: The manufacturer of Cosentyx, which offers several financial assistance programs to help patients access the medication.
4. Dr. Mark Lebwohl: A dermatologist and professor at the Icahn School of Medicine at Mount Sinai, who recommends discussing the cost of treatment with your physician.